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Dear Editor0954-6111/00/101010+01 $35?00/0HTLV-1 activates many cellular genes such as tranforming
growth factor-b, which has been implicated as an important
mediator of pulmonary fibrosis (2). Moreover, HTLV-1
seropositive patients with Adult T-cell Leukaemia have
frequent leukaemic cell infiltration of the lungs accompa-
nied by pulmonary fibrosis (3). We suggest performing
analysis for a possible HTLV-1 infection in patients who
have pulmonary fibrosis associated with pyramidal signs
either they are not originating from known endemic areas
for HTLV-1 infection. Therefore, HTLV-1 may be one of
the different viruses that promote an inflammatory response
contributing to pulmonary fibrosis.
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with human T cell
lymphotropic virus type 1 (HTLV-1)
infection
Most patients suffering from HTLV-1 Associated Myelo-
pathy (HAM) have a subclinical alveolar T lymphocytosis
(1). We report the first case, to our knowledge, of
pulmonary fibrosis in a patient with HAM.
A 35-year-old Mauritanian patient presented with a 6-
months history of progressive dyspnoea. Chest radiography
and thoracic CT scan showed an interstitial penumonitis
without evidence of adenopathy or pleural effusion.
Pulmonary function tests disclosed a restrictive pattern
(total lung capacity, 60% of the predicted value). Bronch-
oalveolar lavage cells count was normal. Open lung biopsy
analysis showed non-specific, interstitial fibrosis. Specific
stains and cultures for pathogens were negative. The patient
was treated with prednisone (30mg day71).
The search for possible HTLV-1 infection was prompted
by a pyramidal syndrome with weakness of both legs
associated with urinary disturbances and bilateral Babinski
sign. Magnetic resonance imaging of the spinal cord was
normal. The patient was seropositive for HTLV-1 by an
enzyme-linked-immunosorbent assay and by Western blot
analysis. No leukaemia-like cells were identified in periph-
eral blood. Three months later, the patient developed
cervical tuberculous lymphadenopathy. He was then lost to
follow-up because he returned to his native country.
HTLV-1 may be implicated as an indirect cause of
pulmonary fibrosis. The viral transactivator protein Tax of# 2000 HARCOURT PUBLISHERS LTD
